Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients

NCT02802605 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

225

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis and Coagulation

Interventions

DRUG: Bemiparin

Sponsor

Instituto de Investigación Marqués de Valdecilla